US2002004528A1PendingUtilityA1
Method for the treatment of insomnia
Priority: Jul 9, 1998Filed: Aug 3, 2001Published: Jan 10, 2002
Est. expiryJul 9, 2018(expired)· nominal 20-yr term from priority
A61P 25/08A61P 25/20A61K 31/195A61K 31/197A61K 31/00
39
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The instant invention is a method of using certain analogs of glutamic acid and gamma-aminobutyric acid to treat insomnia.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for treating a mammal suffering from insomnia comprising administering to said mammal a pharmaceutical composition comprising an effective amount of a GABA analog.
2 . The method according to claim 1 , wherein the GABA analog is the compound according to Formula I:
wherein R 1 is hydrogen or lower alkyl and n is an integer of from 4 to 6, and the pharmaceutically acceptable salts thereof.
3 . The method according to claim 2 , wherein Formula I comprises gabapentin.
4 . The method according to claim 2 , comprising from about 10 mg to about 400 mg of Formula I.
5 . The method according to claim 3 , comprising from about 10 mg to about 400 mg of gabapentin.
6 . The method according to claim 1 , wherein the GABA analog is a compound according to Formula II:
or a pharmaceutically acceptable salt thereof wherein
R 1 is a straight or branched alkyl of from 1 to 6 carbon atoms, phenyl, or cycloalkyl of from 3 to 6 carbon atoms;
R 2 is hydrogen or methyl; and
R 3 is hydrogen, methyl, or carboxyl;
7 . The method according to claim 11 , wherein Formula II comprises pregabalin.
8 . The method according to claim 11 , comprising from about 0.15 mg to about 65 mg of Formula II.
9 . The method according to claim 12 , comprising from about 0.15 mg to about 65 mg of pregabalin.Join the waitlist — get patent alerts
Track US2002004528A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.